STING agonists drive intrinsic type I interferon responses in monocytes for optimal anti-tumor immunity

被引：0
|
作者：
Yu, Tianning
Girard, Melanie
Watts, Tania H.
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2023年 / 11卷 / 12期
关键词：
D O I：
10.1158/2326-6074.TUMIMM23-A012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A012
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy
    Yu, Yasmin
    Bogdan, Madhumita
    Noman, Muhammad Zaeem
    Parpal, Santiago
    Bartolini, Elisabetta
    Van Moer, Kris
    Kleinendorst, Simone Caroline
    Saether, Kristine Bilgrav
    Tresaugues, Lionel
    Silvander, Camilla
    Lindstroem, Johan
    Simeon, Jodi
    Timson, Mary Jane
    Al-Hashimi, Hikmat
    Smith, Bryan D.
    Flynn, Daniel L.
    Alexeyenko, Andrey
    Viklund, Jenny
    Andersson, Martin
    Martinsson, Jessica
    Tamm, Katja Pokrovskaja
    De Milito, Angelo
    Janji, Bassam
    MOLECULAR ONCOLOGY, 2024, 18 (08) : 1904 - 1922
  • [2] The role of type I interferon signaling in myeloid anti-tumor immunity
    Meyer, Sofie Patrizia
    Bauer, Rebekka
    Bruene, Bernhard
    Schmid, Tobias
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [3] Type I Interferon Response in Radiation-Induced Anti-Tumor Immunity
    Zhang, Faya
    Manna, Subrata
    Pop, Laurentiu M.
    Chen, Zhijian J.
    Fu, Yang-Xin
    Hannan, Raquibul
    SEMINARS IN RADIATION ONCOLOGY, 2020, 30 (02) : 129 - 138
  • [4] Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance
    Budhwani, Megha
    Mazzieri, Roberta
    Dolcetti, Riccardo
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [5] Characterizing the role of PCBP1 in the activation of the cGAS-STING/type I Interferon axis to promote anti-tumor immunity
    Frereux, Cecile
    Chakraborty, Paramita
    Dalton, Annamarie C.
    Howley, Breege V.
    Granger, Bryan
    Karam, Joseph A.
    Vaena, Silvia G.
    Romeo, Martin J.
    Howe, Philip H.
    CANCER RESEARCH, 2024, 84 (06)
  • [6] ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity
    Maxwell, Matthew B.
    Hom-Tedla, Marianne S.
    Yi, Jawoon
    Li, Shitian
    Rivera, Samuel A.
    Yu, Jingting
    Burns, Mannix J.
    Mcrae, Helen M.
    Stevenson, Braden T.
    Coakley, Katherine E.
    Ho, Josephine
    Gastelum, Kameneff Bojorquez
    Bell, Joshua C.
    Jones, Alexander C.
    Eskander, Ramez N.
    Dykhuizen, Emily C.
    Shadel, Gerald S.
    Kaech, Susan M.
    Hargreaves, Diana C.
    CELL, 2024, 187 (13) : 3390 - 3408.e19
  • [7] Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity
    Liu, Xiuting
    Hogg, Graham D.
    Zuo, Chong
    Borcherding, Nicholas C.
    Baer, John M.
    Lander, Varintra E.
    Kang, Liang-, I
    Knolhoff, Brett L.
    Ahmad, Faiz
    Osterhout, Robin E.
    V. Galkin, Anna
    Bruey, Jean-Marie
    Carter, Laura L.
    Mpoy, Cedric
    Vij, Kiran R.
    Fields, Ryan C.
    Schwarz, Julie K.
    Park, Haeseong
    Gupta, Vineet
    DeNardo, David G.
    CANCER CELL, 2023, 41 (06) : 1073 - +
  • [8] Discovery of novel STING agonists with robust anti-tumor activity
    Li, Anrong
    Song, Yuntao
    Dong, Chen
    Chen, Xiaoqi
    Yang, Junbao
    CANCER RESEARCH, 2020, 80 (16)
  • [9] 5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING
    Tian, Jingru
    Zhang, Dingyao
    Kurbatov, Vadim
    Wang, Qinrong
    Wang, Yadong
    Fang, Dorthy
    Wu, Lizhen
    Bosenberg, Marcus
    Muzumdar, Mandar D.
    Khan, Sajid
    Lu, Qianjin
    Yan, Qin
    Lu, Jun
    EMBO JOURNAL, 2021, 40 (07):
  • [10] Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
    Leventhal, Daniel S.
    Sokolovska, Anna
    Li, Ning
    Plescia, Christopher
    Kolodziej, Starsha A.
    Gallant, Carey W.
    Christmas, Rudy
    Gao, Jian-Rong
    James, Michael J.
    Abin-Fuentes, Andres
    Momin, Munira
    Bergeron, Christopher
    Fisher, Adam
    Miller, Paul F.
    West, Kip A.
    Lora, Jose M.
    NATURE COMMUNICATIONS, 2020, 11 (01)
12345